ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,850Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 58

$380K Total Retail Price of All Prescriptions

Rank: 19 out of 58

658 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 658 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 13,541 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$26 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOXYL 905 860 1 34
LOVASTATIN 831 764 2 15
AMLODIPINE BESYLATE 784 711 3 2
OMEPRAZOLE 670 597 4 4
SIMVASTATIN 664 626 5 1
LISINOPRIL 644 574 6 3
LOSARTAN POTASSIUM 520 494 7 13
TRIAMTERENE-HCTZ 483 461 8 40
METOPROLOL TARTRATE 430 410 9 6
WARFARIN SODIUM 401 375 10 12
ATENOLOL 388 363 11 9
ENALAPRIL MALEATE 379 346 12 35
METFORMIN HCL 352 284 13 8
ALENDRONATE SODIUM 348 321 14 18
FUROSEMIDE 308 268 15 7
GEMFIBROZIL 305 283 16 56
ATORVASTATIN CALCIUM 288 272 17 17
K-TAB 285 248 18 86
NIFEDIPINE ER 279 272 19 53
HYDROCHLOROTHIAZIDE 230 209 20 10
PAROXETINE HCL 190 179 21 60
VENTOLIN HFA 183 169 22 91
FLUTICASONE PROPIONATE 166 155 23 27
GLYBURIDE 151 122 R 24 52
CITALOPRAM HBR 149 141 25 28
HYDROCODONE-ACETAMINOPHEN 146 140 S3 26 11
SERTRALINE HCL 138 120 27 30
CRESTOR 116 89 28 23
LANOXIN 116 116 28 101
PANTOPRAZOLE SODIUM 114 89 30 46
GABAPENTIN 111 102 31 14
PRAVASTATIN SODIUM 108 100 32 19
ALLOPURINOL 106 106 33 38
TERAZOSIN HCL 101 95 34 73
DILTIAZEM 24HR CD 100 89 35 131
VERAPAMIL ER 91 85 36 95
ZOLPIDEM TARTRATE 88 82 37 16
TRAMADOL HCL 80 72 38 20
CYCLOBENZAPRINE HCL 77 54 R 39 69
FLUOXETINE HCL 75 74 40 78
AMITRIPTYLINE HCL 71 41 R 41 90
MICARDIS 71 67 41 192
NIFEDIAC CC 69 69 43 196
TAMSULOSIN HCL 69 68 43 37
GLIMEPIRIDE 67 66 45 63
MELOXICAM 64 51 46 36
AZITHROMYCIN 62 59 47 33
DONEPEZIL HCL 60 60 48 29
LANSOPRAZOLE 59 45 49 113
RANITIDINE HCL 59 59 49 48
CIPROFLOXACIN HCL 54 52 51 54
DICLOFENAC SODIUM 54 49 51 74
ESCITALOPRAM OXALATE 53 44 53 66
CLONIDINE HCL 51 48 54 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.